These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20131422)

  • 1. [Chagas disease screening in the blood donor population].
    Assal A; Pelletier B; David B; Tiberghien P
    Bull Soc Pathol Exot; 2009 Dec; 102(5):291-4. PubMed ID: 20131422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chagas disease and blood transfusion: an emerging issue in non-endemic countries].
    Assal A; Corbi C
    Transfus Clin Biol; 2011 Apr; 18(2):286-91. PubMed ID: 21440479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain).
    Piron M; Vergés M; Muñoz J; Casamitjana N; Sanz S; Maymó RM; Hernández JM; Puig L; Portús M; Gascón J; Sauleda S
    Transfusion; 2008 Sep; 48(9):1862-8. PubMed ID: 18522707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing blood donors for Chagas disease in the Paris area, France: first results after 18 months of screening.
    El Ghouzzi MH; Boiret E; Wind F; Brochard C; Fittere S; Paris L; Mazier D; Sansonetti N; Bierling P
    Transfusion; 2010 Mar; 50(3):575-83. PubMed ID: 19906038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The early implementation of Trypanosoma cruzi antibody screening of donors and donations within England: preempting a problem.
    Kitchen AD; Hewitt PE; Chiodini PL
    Transfusion; 2012 Sep; 52(9):1931-9. PubMed ID: 22414025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serological screening for Trypanosoma cruzi among blood donors in central Brazil].
    de Andrade AL; Martelli CM; Luquetti AO; de Oliveira OS; Almeida e Silva S; Zicker F
    Bol Oficina Sanit Panam; 1992 Jul; 113(1):19-27. PubMed ID: 1642781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on seroprevalence of anti-Trypanosoma cruzi antibodies among blood donors in northeast Mexico.
    Galavíz-Silva L; Molina-Garza DP; González-Santos MA; Mercado-Hernández R; González-Galavíz JR; Rosales-Encina JL; Molina-Garza ZJ
    Am J Trop Med Hyg; 2009 Sep; 81(3):404-6. PubMed ID: 19706904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Think screening unnecessary, unrealistic for all blood donors.
    Whittemore JC; Salman MD
    J Am Vet Med Assoc; 2003 Jun; 222(11):1502; author reply 1502. PubMed ID: 12784944
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical and epidemiological study of blood donors seropositive for Trypanosoma cruzi].
    García A; Célis D; León M; León P; Macchiavello N; Miranda JP; Tassara R; Denegri M; Lorca M
    Rev Med Chil; 1997 Aug; 125(8):905-10. PubMed ID: 9567394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of antibodies against Trypanosoma cruzi in blood donors].
    Ramos-Echevarria AA; Monteón-Padilla VM; Reyes-López PA
    Salud Publica Mex; 1993; 35(1):56-64. PubMed ID: 8470021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European strategies against the parasite transfusion risk.
    Reesink HW
    Transfus Clin Biol; 2005 Feb; 12(1):1-4. PubMed ID: 15814284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience of targeted screening of Chagas disease in Ile-de-France].
    Lescure FX; Paris L; Elghouzzi MH; Le Loup G; Develoux M; Touafek F; Mazier D; Pialoux G
    Bull Soc Pathol Exot; 2009 Dec; 102(5):295-9. PubMed ID: 20131423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a new enzyme-linked immunosorbent assay for detection of Chagas antibody in US blood donors.
    Tobler LH; Contestable P; Pitina L; Groth H; Shaffer S; Blackburn GR; Warren H; Lee SR; Busch MP
    Transfusion; 2007 Jan; 47(1):90-6. PubMed ID: 17207235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of antibodies to Trypanosoma cruzi among solid organ donors in Southern California: a population at risk.
    Nowicki MJ; Chinchilla C; Corado L; Matsuoka L; Selby R; Steurer F; Mone T; Mendez R; Aswad S
    Transplantation; 2006 Feb; 81(3):477-9. PubMed ID: 16477238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A confirmatory diagnosis of antibodies anti-Trypanosoma cruzi in donors referred by blood banks in Venezuela].
    Díaz-Bello Z; Zavala-Jaspe R; Díaz-Villalobos M; Mauriello L; Maekelt A; de Noya BA
    Invest Clin; 2008 Jun; 49(2):141-50. PubMed ID: 18717262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Guidelines for Chagas disease: Part III. Chagas disease in donors to blood banks].
    Apt B W; Heitmann G I; Jercic L MI; Jotré M L; Muñoz C del V P; Noemí H I; San Martin V AM; Sapunar P J; Torres H M; Zulantay A I
    Rev Chilena Infectol; 2008 Aug; 25(4):285-8. PubMed ID: 18769776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Parasitological and epidemiological aspects of Trypanosoma cruzi seropositive blood donors].
    Galaz P; García S; Mercado R; Orrego E; Pagliero B; Contreras Mdel C; Salinas P; Arancibia C
    Rev Med Chil; 2007 Oct; 135(10):1291-5. PubMed ID: 18180836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chagas' disease: lessons from routine donation testing.
    Castro E
    Transfus Med; 2009 Feb; 19(1):16-23. PubMed ID: 19302451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Trypanosoma cruzi antibodies in blood donors from Veracruz State, Mexico.
    Hernández-Romano P; Cámara-Contreras M; Bravo-Sarmiento E; López-Balderas N
    Transfusion; 2015 Mar; 55(3):647-56. PubMed ID: 25208459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region.
    Pirard M; Iihoshi N; Boelaert M; Basanta P; López F; Van der Stuyft P
    Transfusion; 2005 Apr; 45(4):554-61. PubMed ID: 15819677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.